Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilitiesJohannes Foßelteder, Andreas Reinisch, Christine Beham‐Schmid et al.|Leukemia|2023Cited by 20
Modeling the Development of <i>SRSF2</i> Mutated Myeloid Malignancies By CRISPR/Cas9 Mediated Genome Engineering of Primary Human Hematopoietic Stem and Progenitor CellsGabriel Pabst, Andreas Reinisch, Johannes Foßelteder et al.|Blood|2021Cited by 4
Introduction and Genetic Correction of Calreticulin Mutations in Human Hematopoietic Stem and Progenitor Cells Sheds Light on MPN PathogenesisJohannes Foßelteder, Andreas Reinisch, Angelika Schlacher et al.|Blood|2021Cited by 0